SLFN5 has been shown to promote tumourigenesis in glioblastomas29 and FLVCR1-AS1 knockdown in hepatocellular carcinomas inhibits cell proliferation25. The gene discussed is FLVCR1; the disease is hepatocellular carcinoma.